A feasibility study of autologous tumor-derived HSP70 vaccination against chemotherapy-resistant metastatic breast cancer

被引：0
|
作者：
Li, ZH
Bilgrami, S
Edwards, RL
Bona, RD
Gran, D
Aggarwal, A
Ménoret, A
Srivastava, PK
Tutschka, PJ
机构：
[1] Univ Connecticut, Ctr Hlth, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT 06030 USA
[2] Univ Connecticut, Ctr Hlth, Bone Marrow Transplant Program, Farmington, CT 06030 USA
来源：
CELL STRESS & CHAPERONES | 2000年 / 5卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [1] Chemotherapy-Resistant Metastatic Breast Cancer
    Marquette, Carrie
    Nabell, Lisle
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) : 263 - 275
  • [2] Tumor-derived exosomes with extramembrane HSP70: cancer therapeutic target?
    Gobbo, J.
    FEBS JOURNAL, 2013, 280 : 211 - 211
  • [3] Chemotherapy-Resistant Metastatic Breast Cancer
    Carrie Marquette
    Lisle Nabell
    Current Treatment Options in Oncology, 2012, 13 : 263 - 275
  • [4] New therapeutic options for chemotherapy-resistant metastatic breast cancer
    Pronzato, Paolo
    DRUGS, 2008, 68 (02) : 139 - 146
  • [5] Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
    Gobbo, Jessica
    Marcion, Guillaume
    Cordonnier, Marine
    Dias, Alexandre M. M.
    Pernet, Nicolas
    Hammann, Arlette
    Richaud, Sarah
    Mjahed, Hajare
    Isambert, Nicolas
    Clausse, Victor
    Rebe, Cedric
    Bertaut, Aurelie
    Goussot, Vincent
    Lirussi, Frederic
    Ghiringhelli, Francois
    de Thonel, Aurelie
    Fumoleau, Pierre
    Seigneuric, Renaud
    Garrido, Carmen
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024,
  • [6] Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
    Gobbo, Jessica
    Marcion, Guillaume
    Cordonnier, Marine
    Dias, Alexandre M. M.
    Pernet, Nicolas
    Hammann, Arlette
    Richaud, Sarah
    Mjahed, Hajare
    Isambert, Nicolas
    Clausse, Victor
    Rebe, Cederic
    Bertaut, Aurelie
    Goussot, Vincent
    Lirussi, Frederic
    Ghiringhelli, Francois
    de Thonel, Aurelie
    Fumoleau, Pierre
    Seigneuric, Renaud
    Garrido, Carmen
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (03):
  • [7] Tumor-derived inducible heat-shock protein 70 (HSP70) is an essential component of anti-tumor immunity
    K Dodd
    S Nance
    M Quezada
    L Janke
    J B Morrison
    R T Williams
    H M Beere
    Oncogene, 2015, 34 : 1312 - 1322
  • [8] Tumor-derived inducible heat-shock protein 70 (HSP70) is an essential component of anti-tumor immunity
    Dodd, K.
    Nance, S.
    Quezada, M.
    Janke, L.
    Morrison, J. B.
    Williams, R. T.
    Beere, H. M.
    ONCOGENE, 2015, 34 (10) : 1312 - 1322
  • [9] Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma
    Toomey, Deirdre
    Conroy, Helen
    Jarnicki, Andrew G.
    Higgins, Sarah C.
    Sutton, Caroline
    Mills, Kingston H. G.
    VACCINE, 2008, 26 (27-28) : 3540 - 3549
  • [10] Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and Toxicity
    Sherry, Alexander D.
    Mayer, Ingrid A.
    Ayala-Peacock, Diandra N.
    Abramson, Vandana G.
    Rexer, Brent N.
    Chakravarthy, A. Bapsi
    CLINICAL BREAST CANCER, 2020, 20 (04) : 344 - +
12345